Complement 3 Glomerulopathy (C3G)

Explore clinical trials studying Complement 3 Glomerulopathy (C3G). Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Complement 3 Glomerulopathy (C3G) trial results

Recruiting

NCT07522099

Conditions: Autoimmune Diseases, Complement 3 Glomerulopathy (C3G), Female Urogenital Diseases, +12 more
Locations: ADARx Clinical Site Shenzhen, Guangdong, China

ADARx Clinical Site Guiyang, Guizhou, China

ADARx Clinical Site Zhengzhou, Henan, China

ADARx Clinical Site Baotou, Inner Mongolia, China

Completed

NCT04572854

Conditions: C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Keck School of Medicine, University of Southern California Los Angeles, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Mayo Clinic Rochester, Minnesota, United States

View all 25 locations

Completed

NCT05067127

Conditions: C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Academic Medical Research Institute Los Angeles, California, United States

Keck School of Medicine, University of Southern California Los Angeles, California, United States

Ronald Reagan UCLA Medical Center (01035) Los Angeles, California, United States

View all 125 locations

Active, Not Recruiting

NCT05809531

Conditions: C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations: Academic Medical Research Institute (01034) Los Angeles, California, United States

Children's Hospital Colorado (01037) Aurora, Colorado, United States

University of Florida, Department of Pediatric Nephrology (01010) Gainsville, Florida, United States

Emory Investigational Drug Service (01021) Atlanta, Georgia, United States

View all 47 locations